STOK
Price
$11.49
Change
-$0.19 (-1.63%)
Updated
Dec 23, 12:17 PM (EDT)
72 days until earnings call
STRO
Price
$1.88
Change
-$0.00 (-0.00%)
Updated
Dec 23, 12:16 PM (EDT)
93 days until earnings call
Ad is loading...

STOK vs STRO

Header iconSTOK vs STRO Comparison
Open Charts STOK vs STROBanner chart's image
Stoke Therapeutics
Price$11.49
Change-$0.19 (-1.63%)
Volume$333
CapitalizationN/A
Sutro Biopharma
Price$1.88
Change-$0.00 (-0.00%)
Volume$2.31K
CapitalizationN/A
STOK vs STRO Comparison Chart
Loading...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STOK vs. STRO commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STOK is a Hold and STRO is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (STOK: $11.68 vs. STRO: $1.88)
Brand notoriety: STOK and STRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: STOK: 222% vs. STRO: 231%
Market capitalization -- STOK: $618.65M vs. STRO: $155.02M
STOK [@Biotechnology] is valued at $618.65M. STRO’s [@Biotechnology] market capitalization is $155.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STOK’s FA Score shows that 0 FA rating(s) are green whileSTRO’s FA Score has 1 green FA rating(s).

  • STOK’s FA Score: 0 green, 5 red.
  • STRO’s FA Score: 1 green, 4 red.
According to our system of comparison, STOK is a better buy in the long-term than STRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STOK’s TA Score shows that 3 TA indicator(s) are bullish while STRO’s TA Score has 4 bullish TA indicator(s).

  • STOK’s TA Score: 3 bullish, 8 bearish.
  • STRO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, STRO is a better buy in the short-term than STOK.

Price Growth

STOK (@Biotechnology) experienced а -3.15% price change this week, while STRO (@Biotechnology) price change was -11.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

STOK is expected to report earnings on Mar 05, 2025.

STRO is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($619M) has a higher market cap than STRO($155M). STOK YTD gains are higher at: 122.053 vs. STRO (-56.177). STRO has higher annual earnings (EBITDA): -69.95M vs. STOK (-115.03M). STRO has more cash in the bank: 388M vs. STOK (239M). STOK has less debt than STRO: STOK (2.3M) vs STRO (24.9M). STRO has higher revenues than STOK: STRO (161M) vs STOK (16.7M).
STOKSTROSTOK / STRO
Capitalization619M155M399%
EBITDA-115.03M-69.95M164%
Gain YTD122.053-56.177-217%
P/E RatioN/AN/A-
Revenue16.7M161M10%
Total Cash239M388M62%
Total Debt2.3M24.9M9%
FUNDAMENTALS RATINGS
STRO: Fundamental Ratings
STRO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
STOKSTRO
RSI
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 20 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Ad is loading...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSEQX58.520.91
+1.58%
Morgan Stanley Inst Growth I
SHXCX13.570.14
+1.04%
American Beacon Shapiro Equity Opps C
SEPCX9.220.07
+0.77%
Saratoga Energy & Basic Materials C
IENIX28.710.17
+0.60%
Invesco Energy R5
ABCIX21.02-2.20
-9.47%
American Beacon The London Co Inc Eq R5

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with NUVB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
+3.36%
NUVB - STOK
51%
Loosely correlated
-0.37%
STRO - STOK
48%
Loosely correlated
+3.30%
INZY - STOK
46%
Loosely correlated
+6.41%
QTTB - STOK
44%
Loosely correlated
+7.49%
DNLI - STOK
43%
Loosely correlated
-0.19%
More

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with NUVB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
+3.30%
NUVB - STRO
51%
Loosely correlated
-0.37%
STOK - STRO
48%
Loosely correlated
+3.36%
ALGS - STRO
44%
Loosely correlated
+3.89%
ALLO - STRO
42%
Loosely correlated
+1.63%
INZY - STRO
41%
Loosely correlated
+6.41%
More